Skip to main content
Clinical Trials/NCT02482623
NCT02482623
Withdrawn
Not Applicable

The Dementia Symptom Management at Home Program: A Bundled Interprofessional Intervention to Improve Dementia Patient-Caregiver Dyad Quality of Care and Quality of Life Through Home Healthcare.

New York University2 sites in 1 countryAugust 1, 2017
ConditionsDementia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Dementia
Sponsor
New York University
Locations
2
Primary Endpoint
Person With Dementia Quality of Life
Status
Withdrawn
Last Updated
3 years ago

Overview

Brief Summary

Persons with dementia and their caregivers are often cared for in the community through home healthcare (HHC). While these patients and their caregivers need significant help and often have difficulty maintaining their quality of life, home healthcare clinicians are often unprepared to care for this population. This study will therefore examine the ability of an integrated, multi-pronged evidence-based practice intervention for home healthcare registered nurses, occupational therapists and physical therapists, the DSM-H, to improve the quality of care and quality of life for persons with dementia and their family caregiver. The investigators will enroll persons with dementia and their family caregiver upon admission to the HHC agency and examine their quality of life over 60 days following admission, comparing those who receive the intervention to those who serve as controls.

Detailed Description

The Dementia Symptom Management at Home (DSM-H) Program is an integrated bundled implementation science intervention to improve interprofessional care in home healthcare (HHC). It consists of training, assessment instruments, patient-caregiver centered care plans and workflow changes. The investigators will perform a cluster randomized controlled clinical trial at a single, urban, non-profit HHC agency, randomizing care teams to either be trained in performing the intervention or serve as controls. The aims of this program are to examine the efficacy of this program to: Aim 1: Measure the effects of DSM-H on pain, neuropsychiatric symptoms, and caregiver rated QOL in the person with dementia receiving HHC. Aim 2: Assess the effects of DSM-H on QOL, burden and depression for the informal caregiver of persons with dementia receiving HHC. Aim 3: Assess the effects of DSM-H on the number of emergency room visits and hospital admissions.

Registry
clinicaltrials.gov
Start Date
August 1, 2017
End Date
March 1, 2018
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • patient-caregiver dyad admitted to the HHC agency
  • Patients must be 65 or older and speak English and/or Spanish.
  • Patient must have an informal caregiver who is at least 18 years old and spends at least 8 hours per week with the patient.
  • Patients must score greater than 4 on the cognitive subscale of the Healthy Aging Brain Care Monitor signifying at least mild impairment

Exclusion Criteria

  • Patients with concomitant axis I disorders other than dementia, depression, adjustment disorders, sleep disorders.
  • Patients being seen only in the behavioral health unit without another skilled need.

Outcomes

Primary Outcomes

Person With Dementia Quality of Life

Time Frame: 60 Days

Quality of Life in Alzheimer's Disease survey instrument

Caregiver Quality of Life

Time Frame: 60 Days

Caregiver Targeted Quality of Life survey instrument

Secondary Outcomes

  • Person with Dementia Neuropsychiatric Symptom Burden(60 days)
  • Person with Dementia ER Visits(30, 60 days)
  • Person with Dementia Hospital Admissions(30, 60 days)
  • Person with Dementia Pain(60 days)
  • Caregiver Depression(60 days)
  • Person with Dementia Functional Status(60 days)

Study Sites (2)

Loading locations...

Similar Trials